169 related articles for article (PubMed ID: 20506057)
1. Society for biomolecular sciences - 16th annual conference & exhibition - advancing the science of drug discovery.
Napper AD
IDrugs; 2010 Jun; 13(6):372-5. PubMed ID: 20506057
[TBL] [Abstract][Full Text] [Related]
2. American Society of Clinical Oncology--46th annual meeting.
Al-Shamahi A; Murch L; Kirkham K
IDrugs; 2010 Aug; 13(8):506-9. PubMed ID: 20721815
[TBL] [Abstract][Full Text] [Related]
3. Metastasis and the Tumor Microenvironment: A Joint Metastasis Research Society-AACR Conference - Research on Metastasis: part 2.
Eccles SA
IDrugs; 2010 Nov; 13(11):768-71. PubMed ID: 21046523
[TBL] [Abstract][Full Text] [Related]
4. Molecular Medicine - CHI's 17th International Tri-Conference: Mastering Medicinal Chemistry - CHI's Seventh Annual Conference.
Terrett N
IDrugs; 2010 Apr; 13(4):209-13. PubMed ID: 20373245
[TBL] [Abstract][Full Text] [Related]
5. Ubiquitin Drug Discovery & Diagnostics 2009 - First Annual Conference.
Marblestone JG
IDrugs; 2009 Dec; 12(12):750-3. PubMed ID: 19943215
[TBL] [Abstract][Full Text] [Related]
6. American association for cancer research - 101st annual meeting - investigating new therapeutic candidates: part 2.
Mason VL
IDrugs; 2010 Jun; 13(6):360-2. PubMed ID: 20506053
[TBL] [Abstract][Full Text] [Related]
7. International Drug Discovery Science and Technology--BIT's Seventh Annual Congress.
Bodovitz S
IDrugs; 2010 Jan; 13(1):23-5. PubMed ID: 20024843
[TBL] [Abstract][Full Text] [Related]
8. Medichem--BIT Life Sciences' First Annual International Conference.
Corson TW
IDrugs; 2010 Jul; 13(7):453-6. PubMed ID: 20582869
[TBL] [Abstract][Full Text] [Related]
9. 32nd National Medicinal Chemistry Symposium--medicinal chemistry developments for cancer, and cardiovascular, metabolic and psychiatric disorders.
Gater D
IDrugs; 2010 Aug; 13(8):517-9. PubMed ID: 20721818
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of Cell Death and Disease: Advances in Therapeutic Intervention and Drug Discovery--ESH's Eighth International Conference. October 14-17, 2010, Cascais, Portugal.
Vucic D
IDrugs; 2010 Dec; 13(12):836-9. PubMed ID: 21154138
[TBL] [Abstract][Full Text] [Related]
11. Development, Potential Anticancer Activity and the Receptor Profile of Different Functionalized 1,3,5-Triazine Derivatives.
Sarhan MO; Motaleb MA; Ibrahim IT; Anwar MM; Zaghary WA
Mini Rev Med Chem; 2018; 18(15):1302-1320. PubMed ID: 28971773
[TBL] [Abstract][Full Text] [Related]
12. Asthma & COPD - SMi's sixth annual conference.
Shah S
IDrugs; 2010 Jun; 13(6):376-8. PubMed ID: 20506058
[TBL] [Abstract][Full Text] [Related]
13. AACR-NCI-EORTC--21st International Symposium. Molecular targets and cancer therapeutics--Part 2.
Walker K; Padhiar M
IDrugs; 2010 Jan; 13(1):10-2. PubMed ID: 20024839
[TBL] [Abstract][Full Text] [Related]
14. Lead generation of heat shock protein 90 inhibitors by a combination of fragment-based approach, virtual screening, and structure-based drug design.
Miura T; Fukami TA; Hasegawa K; Ono N; Suda A; Shindo H; Yoon DO; Kim SJ; Na YJ; Aoki Y; Shimma N; Tsukuda T; Shiratori Y
Bioorg Med Chem Lett; 2011 Oct; 21(19):5778-83. PubMed ID: 21875802
[TBL] [Abstract][Full Text] [Related]
15. Natural peptides to drugs - fourth international congress.
Leone-Bay A
IDrugs; 2010 Jun; 13(6):369-71. PubMed ID: 20506056
[TBL] [Abstract][Full Text] [Related]
16. American Chemical Society--233rd National Meeting. Novel drugs for the treatment of cancer. 25-29 March 2007, Chicago, IL, USA.
Turner B; Bright J
IDrugs; 2007 May; 10(5):300-1. PubMed ID: 17487775
[No Abstract] [Full Text] [Related]
17. The HSP90 inhibitor NVP-AUY922-AG inhibits the PI3K and IKK signalling pathways and synergizes with cytarabine in acute myeloid leukaemia cells.
Walsby EJ; Lazenby M; Pepper CJ; Knapper S; Burnett AK
Br J Haematol; 2013 Apr; 161(1):57-67. PubMed ID: 23356405
[TBL] [Abstract][Full Text] [Related]
18. Drugging the cancer kinome: progress and challenges in developing personalized molecular cancer therapeutics.
Workman P
Cold Spring Harb Symp Quant Biol; 2005; 70():499-515. PubMed ID: 16869789
[TBL] [Abstract][Full Text] [Related]
19. Natural Product Inspired N-Terminal Hsp90 Inhibitors: From Bench to Bedside?
Khandelwal A; Crowley VM; Blagg BSJ
Med Res Rev; 2016 Jan; 36(1):92-118. PubMed ID: 26010985
[TBL] [Abstract][Full Text] [Related]
20. HSP90 inhibitors: current development and potential in cancer therapy.
Sidera K; Patsavoudi E
Recent Pat Anticancer Drug Discov; 2014 Jan; 9(1):1-20. PubMed ID: 23312026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
